From CSRxP <[email protected]>
Subject CSRxP Statement on the Launch of TrumpRx
Date February 6, 2026 4:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Campaign Appreciates Administration’s Commitment to Lowering Drug Prices,
Encourages Administration and Congress to Deliver Lasting Relief for American
People by Holding Big Pharma Accountable









CSRxP Statement on the Launch of TrumpRx



Campaign Appreciates Administration’s Commitment to Lowering Drug Prices,
Encourages Administration and Congress to Deliver Lasting Relief for American
People by Holding Big Pharma Accountable



Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a
statement Friday on the launch of TrumpRx.



“CSRxP appreciates the Administration’s commitment to lowering drug prices for
the American people and looks forward to reviewing the full details of
TrumpRx,” said CSRxP executive director Lauren Aronson. “To deliver lasting
relief from Big Pharma’s price-gouging and foster greater affordability for the
American people with sustainable change, Congress and the Administration must
advance market-based solutions to hold Big Pharma accountable for their
anti-competitive tactics and egregious pricing practices that are the root
cause of high prescription drug prices in America.”



Read more on bipartisan, market-based solutions to lower drug prices by
holding Big Pharma accountableHERE <[link removed]>.



###

































Copyright © 2019 Campaign for Sustainable Rx Pricing
Our address is 1341 G St NW, #1100, Washington, DC xxxxxx


This email was sent to [email protected]. To unsubscribe please click
here.
<[link removed]>
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a
  • Email Providers:
    • Iterable